Tissue Distribution and Efficacy of Gold Nanorods Coupled with Laser Induced Photoplasmonic Therapy in Ehrlich Carcinoma Solid Tumor Model

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  El Sayed, Mostafa A ^a   Shabaka, Ali A ^b   El Shabrawy, Osama A ^b   Yassin, Nemat A ^b   Mahmoud, Sawsan S ^b   El Shenawy, Siham M ^b   Al Ashqar, Emad ^b   Eisa, Wael H ^b   Farag, Niveen M ^b   El Shaer, Marwa A ^b   Salah, Nabila ^b   Al Abd, Ahmed M ^b,c  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b NATIONAL RESEARCH CENTRE   (Egypt)

^c KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; PEGYLATED GOLD NANOROD; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BRAIN; CANCER INHIBITION; CANCER THERAPY; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG EXPOSURE; DRUG HALF LIFE; DRUG TISSUE LEVEL; DRUG TUMOR LEVEL; EHRLICH ASCITES TUMOR; FEMALE; HISTOPATHOLOGY; HYALINE DEGENERATION; KIDNEY; LIVER; LOW LEVEL LASER THERAPY; LYMPHOCYTIC INFILTRATION; MALE; MAXIMUM PLASMA CONCENTRATION; MOUSE; NEAR INFRARED LASER PLASMON PHOTOTHERMAL THERAPY; NONHUMAN; PARTICLE SIZE; PHOTOTHERAPY; RAT; SEX DIFFERENCE; SINGLE DRUG DOSE; SPLEEN; TISSUE DISTRIBUTION; TOXICITY TESTING; TUMOR MODEL; TUMOR REGRESSION; TUMOR VOLUME;

ADMINISTRATION, INTRAVENOUS; ANIMALS; CARCINOMA, EHRLICH TUMOR; DISEASE MODELS, ANIMAL; FEMALE; GOLD; HYPERTHERMIA, INDUCED; LASER THERAPY, LOW-LEVEL; MALE; MICE; NANOTUBES; POLYETHYLENE GLYCOLS; TISSUE DISTRIBUTION; TUMOR BURDEN;

EID: 84884845916     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076207     Document Type: Article

References (40)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90. doi:10.3322/caac.20107. PubMed: 21296855.
2. Tunggal JK, Cowan DS, Shaikh H, Tannock IF, (1999) Penetration of anticancer drugs through solid tissue: a factor that limits the effectiveness of chemotherapy for solid tumors. Clin Cancer Res 5: 1583-1586. PubMed: 10389947.
3. Trédan O, Galmarini CM, Patel K, Tannock IF, (2007) Drug resistance and the solid tumor microenvironment. J Natl Cancer Inst 99: 1441-1454. doi:10.1093/jnci/djm135. PubMed: 17895480.
4. Kyle AH, Huxham LA, Yeoman DM, Minchinton AI, (2007) Limited tissue penetration of taxanes: a mechanism for resistance in solid tumors. Clin Cancer Res 13: 2804-2810. doi:10.1158/1078-0432.CCR-06-1941. PubMed: 17473214.
5. Minchinton AI, Tannock IF, (2006) Drug penetration in solid tumours. Nat Rev Cancer 6: 583-592. doi:10.1038/nrc1893. PubMed: 16862189.
6. Hicks KO, Pruijn FB, Sturman JR, Denny WA, Wilson WR, (2003) Multicellular resistance to tirapazamine is due to restricted extravascular transport: a pharmacokinetic/pharmacodynamic study in HT29 multicellular layer cultures. Cancer Res 63: 5970-5977. PubMed: 14522924.
7. Wang X, Chen Y, Ren J, Qu X, (2011) Small interfering RNA for effective cancer therapies. Mini Rev Med Chem 11: 114-124. doi:10.2174/138955711794519528. PubMed: 21222575.
8. Dua P, Kim S, Lee DK, (2011) Nucleic acid aptamers targeting cell-surface proteins. Methods 54: 215-225. doi:10.1016/j.ymeth.2011.02.002. PubMed: 21300154.
9. Lassen U, Nielsen DL, Sørensen M, Winstedt L, Niskanen T, et al. (2012) A phase I, dose-escalation study of TB-403, a monoclonal antibody directed against PlGF, in patients with advanced solid tumours. Br J Cancer 106: 678-684. doi:10.1038/bjc.2011.609. PubMed: 22333707.
10. Schroeder A, Heller DA, Winslow MM, Dahlman JE, Pratt GW, et al. (2012) Treating metastatic cancer with nanotechnology. Nat Rev Cancer 12: 39-50. PubMed: 22193407.
11. Al-Abd AM, Lee SH, Kim SH, Cha JH, Park TG, et al. (2009) Penetration and efficacy of VEGF siRNA using polyelectrolyte complex micelles in a human solid tumor model in-vitro. J Control Release 137: 130-135. doi:10.1016/j.jconrel.2009.03.009. PubMed: 19306899.
12. Chen T, Shukoor MI, Chen Y, Yuan Q, Zhu Z, et al. (2011) Aptamer-conjugated nanomaterials for bioanalysis and biotechnology applications. Nanoscale 3: 546-556. doi:10.1039/c0nr00646g. PubMed: 21109879.
13. Huang HC, Barua S, Sharma G, Dey SK, Rege K, (2011) Inorganic nanoparticles for cancer imaging and therapy. J Control Release 155: 344-357. doi:10.1016/j.jconrel.2011.06.004. PubMed: 21723891.
14. Shan L, (2004) Polyethylene glycol-coated (PEG5000) gold nanoparticles.
15. Yamashita S, Fukushima H, Akiyama Y, Niidome Y, Mori T, et al. (2011) Controlled-release system of single-stranded DNA triggered by the photothermal effect of gold nanorods and its in vivo application. Bioorg Med Chem 19: 2130-2135. doi:10.1016/j.bmc.2011.02.042. PubMed: 21421321.
16. Huang P, Bao L, Zhang C, Lin J, Luo T, et al. (2011) Folic acid-conjugated silica-modified gold nanorods for X-ray/CT imaging-guided dual-mode radiation and photo-thermal therapy. Biomaterials 32: 9796-9809. doi:10.1016/j.biomaterials.2011.08.086. PubMed: 21917309.
17. Yang DP, Cui DX, (2008) Advances and prospects of gold nanorods. Chem Asian J 3: 2010-2022. doi:10.1002/asia.200800195. PubMed: 18956474.
18. Choi WI, Sahu A, Kim YH, Tae G, (2011) Photothermal Cancer Therapy and Imaging Based on Gold Nanorods. Ann Biomed Eng, 40: 534-46. PubMed: 21887589.
19. Huang X, Jain PK, El-Sayed IH, El-Sayed MA, (2008) Plasmonic photothermal therapy (PPTT) using gold nanoparticles. Lasers Med Sci 23: 217-228. doi:10.1007/s10103-007-0470-x. PubMed: 17674122.
20. Gormley AJ, Greish K, Ray A, Robinson R, Gustafson JA, et al. (2011) Gold nanorod mediated plasmonic photothermal therapy: a tool to enhance macromolecular delivery. Int J Pharm 415: 315-318. doi:10.1016/j.ijpharm.2011.05.068. PubMed: 21669265.
21. Li Z, Huang P, Zhang X, Lin J, Yang S, et al. (2010) RGD-conjugated dendrimer-modified gold nanorods for in vivo tumor targeting and photothermal therapy. Mol Pharm 7: 94-104. doi:10.1021/mp9001415. PubMed: 19891496.
22. Akiyama Y, Mori T, Katayama Y, Niidome T, (2009) The effects of PEG grafting level and injection dose on gold nanorod biodistribution in the tumor-bearing mice. J Control Release 139: 81-84. doi:10.1016/j.jconrel.2009.06.006. PubMed: 19538994.
23. Pissuwan D, Valenzuela S, Cortie MB, (2008) Prospects for gold nanorod particles in diagnostic and therapeutic applications. Biotechnol Genet Eng Rev 25: 93-112. doi:10.5661/bger-25-93. PubMed: 21412351.
24. Bogliotti N, Oberleitner B, Di-Cicco A, Schmidt F, Florent JC, et al. (2011) Optimizing the formation of biocompatible gold nanorods for cancer research: functionalization, stabilization and purification. J Colloid Interface Sci 357: 75-81. doi:10.1016/j.jcis.2011.01.053. PubMed: 21334635.
25. Boca SC, Astilean S, (2010) Detoxification of gold nanorods by conjugation with thiolated poly(ethylene glycol) and their assessment as SERS-active carriers of Raman tags. Nanotechnology 21: 235601. doi:10.1088/0957-4484/21/23/235601. PubMed: 20463383.
26. Hainfeld JF, Slatkin DN, Smilowitz HM, (2004) The use of gold nanoparticles to enhance radiotherapy in mice. Phys Med Biol, 49N309-315. PubMed: 15509078.
27. Kopwitthaya A, Yong KT, Hu R, Roy I, Ding H, et al. (2010) Biocompatible PEGylated gold nanorods as colored contrast agents for targeted in vivo cancer applications. Nanotechnology 21: 315101. doi:10.1088/0957-4484/21/31/315101. PubMed: 20622303.
28. Goodrich GP, Bao L, Gill-Sharp K, Sang KL, Wang J, et al. (2010) Photothermal therapy in a murine colon cancer model using near-infrared absorbing gold nanorods. J Biomed Opt 15: 018001. doi:10.1117/1.3290817. PubMed: 20210487.
29. Niidome T, Akiyama Y, Yamagata M, Kawano T, Mori T, et al. (2009) Poly(ethylene glycol)-modified gold nanorods as a photothermal nanodevice for hyperthermia. J Biomater Sci Polym Ed 20: 1203-1215 doi:10.1163/156856209X452953. PubMed: 19520008.
30. Agarwal A, Mackey MA, El-Sayed MA, Bellamkonda RV, (2011) Remote triggered release of doxorubicin in tumors by synergistic application of thermosensitive liposomes and gold nanorods. ACS Nano 5: 4919-4926. doi:10.1021/nn201010q. PubMed: 21591812.
31. Malugin A, Ghandehari H, (2010) Cellular uptake and toxicity of gold nanoparticles in prostate cancer cells: a comparative study of rods and spheres. J Appl Toxicol 30: 212-217. PubMed: 19902477.
32. Niidome T, Ohga A, Akiyama Y, Watanabe K, Niidome Y, et al. (2010) Controlled release of PEG chain from gold nanorods: targeted delivery to tumor. Bioorg Med Chem 18: 4453-4458. doi:10.1016/j.bmc.2010.04.070. PubMed: 20472443.
33. Li PC, Wang CR, Shieh DB, Wei CW, Liao CK, et al. (2008) In vivo photoacoustic molecular imaging with simultaneous multiple selective targeting using antibody-conjugated gold nanorods. Opt Express 16: 18605-18615. doi:10.1364/OE.16.018605. PubMed: 19581946.
34. Gormley AJ, Malugin A, Ray A, Robinson R, Ghandehari H, (2011) Biological evaluation of RGDfK-gold nanorod conjugates for prostate cancer treatment. J Drug Target 19: 915-924. doi:10.3109/1061186X.2011.623701. PubMed: 22082105.
35. Arnida, Janat-Amsbury MM, Ray A, Peterson CM, Ghandehari H (2011) Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages. Eur J Pharm Biopharm 77: 417-423. doi:10.1016/j.ejpb.2010.11.010. PubMed: 21093587.
36. Dickerson EB, Dreaden EC, Huang X, El-Sayed IH, Chu H, et al. (2008) Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice. Cancer Lett 269: 57-66. doi:10.1016/j.canlet.2008.04.026. PubMed: 18541363.
37. Huang YF, Sefah K, Bamrungsap S, Chang HT, Tan W, (2008) Selective photothermal therapy for mixed cancer cells using aptamer-conjugated nanorods. Langmuir 24: 11860-11865. doi:10.1021/la801969c. PubMed: 18817428.
38. Huff TB, Tong L, Zhao Y, Hansen MN, Cheng JX, et al. (2007) Hyperthermic effects of gold nanorods on tumor cells. Nanomedicine (Lond) 2: 125-132. doi:10.2217/17435889.2.1.125. PubMed: 17716198.
39. Gu M, Bao HC, Li JL, (2010) Cancer-cell microsurgery using nonlinear optical endomicroscopy. J Biomed Opt 15: 050502. doi:10.1117/1.3502566. PubMed: 21054074.
40. Nikoobakht B, El-Sayed MA, (2003) Preparation and Growth Mechanism of Gold Nanorods (NRs) Using Seed-Mediated Growth Method. Chem Mater 15: 1957-1962. doi:10.1021/cm020732l.